Estimation of the maximum potential cost saving from reducing serious adverse events in hospitalized patients

被引:0
|
作者
Larsen, Arendse Tange [1 ]
Sopina, Liza [2 ]
Aasvang, Eske Kvanner [3 ,4 ]
Meyhoff, Christian Sylvest [4 ,5 ]
Kristensen, Soren Rud [6 ]
Kjellberg, Jakob [1 ]
机构
[1] VIVE Danish Ctr Social Sci Res, VIVE Hlth, Copenhagen, Denmark
[2] Univ Southern Denmark, Danish Ctr Hlth Econ, Odense, Denmark
[3] Univ Copenhagen, Ctr Canc & Organ Dis, Dept Anaesthesiol, Rigshosp, Copenhagen, Denmark
[4] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark
[5] Copenhagen Univ Hosp Bispebjerg & Frederiksberg, Dept Anaesthesia & Intens Care, Copenhagen, Denmark
[6] Univ Southern Denmark, DaCHE Danish Ctr Hlth Econ, Odense, Denmark
关键词
artificial intelligence; continuous vital signs monitoring; cost savings; health economic; serious adverse events; ARTIFICIAL-INTELLIGENCE; HEALTH-CARE; IMPACT;
D O I
10.1111/aas.14525
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Purpose: The increasing use of advanced medical technologies to detect adverse events, for instance, artificial intelligence-assisted technologies, has shown promise in improving various aspects within health care but may also come with substantial expenses. Therefore, understanding the potential economic benefits can guide decision-making processes regarding implementation. We aimed to estimate the potential cost savings associated with reducing length of stay and avoiding readmissions within the framework of an artificial intelligence-assisted vital signs monitoring system. Methods: We used data from Danish national registries and coarsened exact matching to estimate the difference in length of stay and probability of readmission among adult in-hospital patients exposed to and not exposed to serious adverse events. We used these estimates to calculate the maximum potential savings that could be achieved by early detection of adverse events to reduce length of stay and avoid readmissions. Results: Patients exposed to serious adverse events during admission had 2.4 (95% CI: 2.4-2.5) additional hospital bed days and had 14% (95% CI 11%-17%) higher odds of readmissions compared with patients not exposed to such events. A base case scenario yielded maximum potential savings if one patient avoided a serious adverse event of EUR 2040 due to reduced length of stay and EUR 43 due to avoidance of readmissions caused by serious adverse events. Conclusion: Reductions in serious adverse events are associated with decreased healthcare costs due to reduced length of stay and avoided readmissions. Artificial intelligence-assisted vital signs monitoring systems are one potential approach to reduce serious adverse events, however, the ability of this technology to reduce adverse events remains unclear. Comprehensive prospective analyses of such systems including the intervention and implementation costs are necessary to understand their full economic impact.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Cost of adverse events for hospitalized patients
    Navarro Espigares, J. L.
    Fernandez Sierra, M. A.
    Rodriguez del Aguila, M. M.
    Hernandez Torres, E.
    Padial Ortiz, M. A.
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2010, 20 : 177 - 178
  • [2] Predictors of Serious Opioid-Related Adverse Drug Events in Hospitalized Patients
    Minhaj, Faisal Syed
    Rappaport, Stephen H.
    Foster, Justin
    Gashlin, Lauren Z.
    [J]. JOURNAL OF PATIENT SAFETY, 2021, 17 (08) : E1585 - E1588
  • [3] Identification of serious iatrogenic OPIOID-related adverse events in hospitalized patients
    Huber, Michelle R.
    Hanson, Monica
    Lobo, Bob
    [J]. PHARMACOTHERAPY, 2012, 32 (10): : E250 - E250
  • [4] SUSPECTED OSA IN HOSPITALIZED PATIENTS: PREVALENCE AND POTENTIAL FOR ADVERSE EVENTS
    Auckley, D.
    Ramsammy, V
    Shalhoub, G. J.
    Khanna, G.
    [J]. SLEEP, 2010, 33 : A136 - A136
  • [5] Risk of Serious Adverse Gastrointestinal Events with Potassium Binders in Hospitalized Patients: A National Study
    Holleck, Juergen L.
    Han, Ling
    Skanderson, Melissa
    Bastian, Lori A.
    Gunderson, Craig G.
    Brandt, Cynthia A.
    Perkal, Melissa
    Chang, John J.
    Akgun, Kathleen M.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2024,
  • [6] Adverse drug events in hospitalized patients
    Raschetti, R
    MennitiIppolito, F
    Morgutti, M
    Belisari, A
    Rossignoli, A
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (17): : 1351 - 1352
  • [8] Adverse Events in Hospitalized Pediatric Patients
    Stockwell, David C.
    Landrigan, Christopher P.
    Toomey, Sara L.
    Loren, Samuel S.
    Jang, Jisun
    Quinn, Jessica A.
    Ashrafzadeh, Sepideh
    Wang, Michelle J.
    Wu, Melody
    Sharek, Paul J.
    Classen, David C.
    Srivastava, Rajendu
    Parry, Gareth
    Schuster, Mark A.
    [J]. PEDIATRICS, 2018, 142 (02)
  • [9] Cost of serious adverse events in a community teaching hospital, in Mexico
    Meave Gutierrez-Mendoza, Luis
    Torres-Montes, Abraham
    Soria-Orozco, Manuel
    Padron-Salas, Aldanely
    Elizabeth Ramirez-Hernandez, Maria
    [J]. CIRUGIA Y CIRUJANOS, 2015, 83 (03): : 211 - 216
  • [10] Analysis of falls that caused serious events in hospitalized patients
    Kobayashi, Kazuyoshi
    Imagama, Shiro
    Ando, Kei
    Inagaki, Yuko
    Suzuki, Yusuke
    Nishida, Yoshihiro
    Nagao, Yoshimasa
    Ishiguro, Naoki
    [J]. GERIATRICS & GERONTOLOGY INTERNATIONAL, 2017, 17 (12) : 2403 - 2406